Aim: To determine whether the anti-inflammatory effect of minocycline on postischemic brain injury is mediated by the inhibition of 5-lipoxygenase (5-LOX) expression and enzymatic activation in rats. Methods: Focal cerebral ischemia was induced for 30 min with middle cerebral artery occlusion, followed by reperfusion. The ischemic injuries, endogenous IgG exudation, the accumulation of neutrophils and macrophage/microglia, and 5-LOX mRNA expression were determined 72 h after reperfusion. 5-LOX metabolites (leukotriene B 4 and cysteinyl leukotrienes) were measured 3 h after reperfusion. Results: Minocycline (22.5 and 45 mg/kg, ip, for 3 d) attenuated ischemic injuries, IgG exudation, and the accumulation of neutrophils and macrophage/microglia 72 h after reperfusion. It also inhibited 5-LOX expression 72 h after reperfusion and the production of leukotrienes 3 h after reperfusion. Conclusion: Minocycline inhibited postischemic brain inflammation, which might be partly mediated by the inhibition of 5-LOX expression and enzymatic activation.
Introduction
Cerebral ischemia evokes secondary inflammation in the brain that contributes to ischemic insults [1] . In the delayed progression of ischemic stroke, postischemic inflammation may play an important role in brain damage [2] . As one of the pro-inflammatory molecules, 5-lipoxygenase (5-LOX) is the rate-limiting enzyme in the metabolism of arachidonic acid to produce leukotrienes, including leukotriene B 4 (LTB 4 ) and cysteinyl leukotrienes [CysLTs, namely leukotriene C 4 (LTC 4 ), LTD 4 and LTE 4 ]. The importance of 5-LOX in stroke has been proven in reports where the gene encoding the 5-LOX activating protein confers the risk of stroke [3, 4] . Experimental studies have shown that the expression and the metabolite production of 5-LOX in the brain are increased after cerebral ischemia, and 5-LOX inhibitors exert neuroprotective effects on cerebral ischemic injury [5] [6] [7] [8] [9] [10] . On the other hand, minocycline, a semisynthetic tetracycline antibiotic, has been reported to possess neuroprotective effects on cerebral ischemic injury [11] [12] [13] [14] [15] and other brain injuries [16] [17] [18] . The neuroprotective effect of minocycline relates to its anti-inflammatory and anti-apoptotic activities, such as inhibiting the activation and proliferation of microglia, the expressions of inducible nitric oxide synthase (iNOS), interleukin-1β converting enzyme and cyclooxygenase-2 [11, 12] , and the caspase-dependent and independent cell apoptotic pathways [16] [17] [18] . However, the anti-inflammatory mechanisms of minocycline are not fully understood.
Recently, we reported that minocycline protected PC12 cells against in vitro ischemic-like injury or N-methyl-Daspartate (NMDA)-induced excitotoxicity, and it could inhibit 5-LOX translocation to the nuclear membranes (a phenomenon of 5-LOX activation) [19, 20] . These findings indicate that the in vitro protective effects of minocycline on ischemic or excitotoxic injuries may be partly mediated by inhibiting 5-LOX activation. In the present study, we determined whether minocycline exerts an in vivo anti-inflammatory effect that is mediated by inhibiting 5-LOX activation after focal cerebral ischemia in rats.
Materials and methods

Measurements of physiological variables
Male SpragueDawley rats weighing 250-300 g (Experimental Animal Center, Zhejiang Academy of Medical Sciences, Hangzhou, China) were used in this study. The animals were housed under a controlled temperature (22±2 °C), 12 h light/dark cycle, and allowed free access to food and water. All experiments were carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals.
The rats were anesthetized with chloral hydrate (400 mg/kg, ip). A polyethylene tube was inserted into the right femoral artery for continuously monitoring the blood pressure using a computer-assisted system (MedLab-U/4cs, Nanjing MedEase, Nanjing, China), and for measuring P aO 2 , P aCO 2 , and arterial blood pH (Blood Gas Analyzer ABL 330, Leidu, Copenhagen, Denmark). Blood glucose was monitored by the One Touch Basic Blood Glucose Monitoring System (Lifescan, Los Angeles, CA, USA). The rectal (core) temperature was measured and maintained at 37.0±0.5 °C with a heating pad and a heating lamp during the surgery. Percent changes in the regional cerebral blood flow (rCBF) over the middle cerebral arterial (MCA) territory (2 mm in diameter; 6 mm lateral and 2 mm caudal to bregma) were recorded as described [21] using a laser Doppler flowmeter (ML191, AD Instruments, Bella Vista, New South Wales, Australia), and the steady baseline value of rCBF before ischemia was 100%.
Middle cerebral artery occlusion Transient focal cerebral ischemia was induced by the suture occlusion method as previously described [22] . Briefly, after anesthesia, a midline incision was made in the neck, the right external carotid artery (ECA) and the right internal carotid artery (ICA) were carefully exposed and dissected, and a 3-0 (0.26 mm diameter) monofilament nylon suture was inserted from the ECA into the ICA to occlude the origin of the right MCA. After occlusion for 30 min, the suture was withdrawn to allow reperfusion, the ECA was ligated, and the incision was closed. The shamoperated rats underwent identical surgery, except that the intraluminal filament was not inserted. The achievement of the middle cerebral artery occlusion (MCAO) was confirmed by a reduction of 50% or more in the rCBF from the baseline value [23] . After surgery, the rats were kept for about 2 h in a warm box heated by lamps to maintain the body temperature.
Minocycline (Syowa Hakko, Tokyo, Japan) dissolved in sterile saline (22.5 and 45 mg/kg) was ip injected at 0.5 and 2 h after reperfusion on the first day, and twice daily on the second and third days. This dosage regimen was based on previous reports in studies of rat global and focal cerebral ischemia [11, 12] . Equal volume (1 mL/kg) of saline was ip injected as the control.
Behavioral assessments Neurological deficit scores were evaluated 72 h after reperfusion according to the described method [24] ; 0, no deficit; 1, flexion of contralateral forelimb upon lifting of the whole animal by the tail; 2, decrease of thrust toward contralateral plane; and 3, circling to the contralateral side. An inclined board test was performed to assess balance and coordination [25] based on the method developed by Yonemori et al [26] . The rats were placed on a board (50 cm×30 cm). Once they were stable, the board was inclined horizontally to vertically. The degree at which the animal fell from the board (holding angle) was recorded. The test was repeated 3 times and the average degree was used. All the behavioral and morphological changes were observed by the investigators who were blind to the treatments.
Histological examination After the behavioral assessments, the rats were anesthetized 72 h after reperfusion, and perfused transcardially with 4% paraformaldehyde after a saline prewash. The brains were removed and postfixed in 4% paraformaldehyde overnight, and transferred to 30% sucrose for 3 d. Six serial coronal slices were cut at 2 mm intervals from the frontal pole. Then, 2 sets of coronal sections (10 and 20 µm) were cut by cryomicrotomy (CM1900, Leica, Wiesbaden, Germany) from the slices. After being stained with 1% toluidine blue, the 20 µm thick sections were used for gross photographic examination, while the 10 µm sections were used for microphotographic or immunohistochemical examination.
In the gross photographs, the lesion area of the brain tissue was defined as an area with reduced Nissl staining, and confirmed by light microscopy to have dark pyknoticnecrotic cell bodies. The lesion areas were determined using an image analysis program (AnalyPower1.0, Zhejiang University, Hangzhou, China). The lesion volume of each section was calculated as: lesion area×slice thickness (2 mm), and the total lesion volume was the summation of the lesion volumes of all sections. In the microphotographs, the neurons in the temporoparietal cortex III and IV layers adjacent to infarcted area (0.2-0.4 mm caudal to bregma) were immunostained with a mouse monoclonal antibody against neuronal nuclei (NeuN) as described later, and neuron density was counted. The neurons or immunostained cells were randomly counted in three 200 µm 2 squares at the upper, middle, and lower sites of the boundary zone adjacent to the ischemic core, and then were averaged.
Immunohistochemical analyses In the 10 µm sections, endogenous peroxidase activity was eliminated by reaction with 3% hydrogen peroxide for 30 min, and non-specific binding of IgG was blocked by incubation with 5% normal goat serum for 2 h at room temperature. The brain sections reacted overnight at 4 °C with a rabbit polyclonal antimyeloperoxidase (MPO, a marker of neutrophils) antibody (1:200, Neomarkers, Fremont, CA, USA) [27] , a mouse mono-clonal anti-CD11b (a marker of macrophage/microglia) antibody (1:200, Serotec, Oxford, UK) [12] , or a rabbit polyclonal antibody against 5-LOX (1:200, Cayman Chemical, Ann Arbor, MI, USA) [28] overnight at 4 °C, then incubated with biotinylated goat anti-rabbit or goat anti-mouse IgG (1:200, Zhongshan Biotechnology, Beijing, China) for 2 h at room temperature, and horseradish peroxidase-streptavidin (1:200, Zhongshan Biotechnology, China) for 60 min. Finally, the sections were exposed for 5-20 min to 0.05% 3, 3'-diamino-benzidine and 0.03% H 2 O 2 .
To visualize the localization of 5-LOX in different cell types, double immunofluorescence was employed. Briefly, after blocking non-specific binding of IgG with 5% normal goat serum for 2 h at room temperature, each section was incubated overnight at 4 °C with a mixture of a rabbit polyclonal antibody against 5-LOX and a mouse monoclonal antibody against neuronal nuclear antigen (NeuN, 1:100, a specific marker of neurons, Chemicon, Temecula, CA, USA) [29] , glial fibrillary acidic protein (GFAP, 1:800, a specific marker of astrocytes, Chemicon, USA) [29] or CD11b (1:200). Then, the sections were incubated with the mixture of fluoresceinisothiocyanate-conjugated goat anti-rabbit IgG and Cy3-conjugated goat anti-mouse IgG (Chemicon, USA). The antiNeuN antibody alone was also used for detecting the neurons.
Endogenous IgG immunostaining was performed to detect blood-brain barrier (BBB) disruption [30] . Cortical sections (3.8-4.0 mm caudal to bregma) reacted respectively and successively with a biotinylated anti-rat IgG antibody (1:200, Sigma Chemical Co, St Louis, MO, USA), horseradish peroxidase-streptavidin (1:200) and 0.05% 3,3'-diaminobenzidine. The stained sections were photographed using a digital camera (FinePix S602 148 Zoom, Fuji, Tokyo, Japan), and analyzed with a computer using image analysis software (Imagetool 2.0, University of Texas Health Science Center, San Antonio, TX, USA). The percentage of immunoreactivity in the sections was determined as follows: [IgG-positive area in ischemic hemisphere/(contralateral hemisphere area)] ×100% [30] .
RT-PCR
In another experiment, the cortical tissues were dissected on ice from the ischemic core and the boundary zone adjacent to the ischemic core 72 h after reperfusion, and stored at -70 °C until use. The control tissues were removed from the cortex of the sham-operated rats corresponding to the ischemic core. The total RNA was extracted using Trizol reagents (Invitrogen, Carlbad, CA, USA) according to the manufacture's protocol. For the cDNA synthesis, 2 µg total RNA was mixed with 1 mmol/L dNTP, 0.2 µg random primer, 20 U RNasin, and 200 U M-MuLV reverse transcriptase in 20 µL reverse reaction buffer. The mixture was incubated at 42 °C for 60 min and then heated at 72 °C for 10 min to inactivate the reverse transcriptase.
PCR Leukotriene measurement In a separate experiment, the ischemic cortexes were quickly isolated on ice 3 h after reperfusion, which was confirmed as the peak time of leukotriene production in our laboratory. The cortical tissues were weighed and homogenized in ice-cold absolute ethanol. After centrifugation of the homogenates at 15 000×g at 4 °C for 30 min, the supernatant was collected and filtrated through a 0.2 µm filtrator. The filtration was dried under nitrogen and resuspended in an ELISA buffer. The tissue contents of LTB 4 and CysLT (the 5-LOX metabolites) were measured according to the protocol of the enzyme immunoassay kit (Cayman Chemical, USA). All measurements were carried out in duplicate.
Statistical analysis Data are expressed as the mean±SD. The differences between the groups were analyzed by oneway ANOVA followed by Student-Newman-Keuls t-test; the neurological deficit score and the percent area of IgG immunoreactivity were analyzed by non-parametric Mann-Whitney U-test (SPSS 10.0 for Windows, 1999, SPSS, Chicago, IL, USA). A value of P<0.05 was considered statistically significant.
Results
Physiological parameters There were no significant differences in the mean arterial blood pressure, arterial blood P aO 2 , P aCO 2 , and blood glucose between 30 min before and 30 min after MCAO among the groups treated with saline and minocycline (22.5 and 45 mg/kg) as well as the sham-operation group. Treatment with minocycline did not affect these physiological parameters. In the ischemic rats, rCBF was reduced by approximately 50%-60% during 30 min MCAO and recovered to nearly baseline levels 15 min after reperfusion; treatment with minocycline did not alter rCBF reduction and recovery (Table 1) .
Ischemic injuries The neurological deficit score increased ( Figure 1A ) and the inclined degrees decreased significantly ( Figure 1B ) 72 h after reperfusion in the MCAO control rats. Minocycline (22.5 and 45 mg/kg) significantly reduced the neurological deficit scores (P<0.05 or 0.01 vs MCAO control, Figure 1A) , and significantly increased the inclined degrees only at the concentration of 45 mg/kg (P<0.01 vs MCAO control, Figure 1B) .
The infarct volume in the ischemic hemispheres was significantly reduced by minocycline (22.5 and 45 mg/kg) 72 h after reperfusion (P<0.01 vs MCAO control, Figure 1C ). The reduced NeuN-positive neuron density in the boundary zone was significantly attenuated by minocycline (22.5 and 45 mg/kg) 72 h after reperfusion (P<0.01 vs MCAO control, Figure 1D ).
Inflammatory reactions
The endogenous IgG immunoreactivity was intensively increased 72 h after reperfusion; minocycline (22.5 and 45 mg/kg) remarkably reduced IgG exudation (P<0.05 or 0.01 vs MCAO control, Figure 2) .
The amount of MPO-positive neutrophils and CD11b-positive macrophage/microglia increased in the ischemic hemispheres 72 h after reperfusion ( Figure 3A, 3B) . Minocycline (22.5 and 45 mg/kg) significantly inhibited neutrophil and macrophage/microglial accumulation (P<0.01 vs MCAO control, Figure 3C, 3D) , as evidenced by MPO and CD11b immunoreactivity, respectively.
Changes in 5-LOX expression and enzymatic activity 5-LOX-positive cells were markedly increased in the ischemic core and boundary zone 72 h after reperfusion ( Figure 4A ), which was inhibited by minocycline (45 mg/kg, P<0.01, Figure 4B ). Double immunofluorescence showed that 5-LOX was primarily localized in NeuN-positive neurons in the ischemic core, and in GFAP-positive astrocytes and CD11b-positive macrophage/microglia in the boundary zone ( Figure 5) ; while 5-LOX expression was much weaker in astrocytes and macrophage/microglia in the ischemic core as well as in neurons in the boundary zone (data not shown). The 5-LOX-positive and CD11b-positive cells were reduced by mino-cycline (right panels in Figure 5 ). 5-LOX mRNA expression was significantly increased in both the ischemic core and the boundary zone 72 h after reperfusion ( Figure 6A ), which was significantly inhibited by minocycline (45 mg/kg, P<0.01 vs MCAO control, Figure  6B ). The contents of LTB 4 and CysLT in the ischemic cortex increased 3 h after reperfusion, which was significantly reduced by minocycline (45 mg/kg, P<0.01 vs MCAO control, Figure 6C , 6D).
Discussion
In the present study, we found that minocycline exerted the anti-inflammatory effects after ischemia/reperfusion injury in rats as previously reported [5] [6] [7] [8] [9] [10] . Minocycline inhibits 5-LOX expression and activation in ischemic brain tissue after focal cerebral ischemia, confirming its ability in PC12 cells [19, 20] . These findings indicate that minocycline might inhibit postischemic inflammation via modulating 5-LOX expression and activation.
In postischemic brain inflammation in the subacute phase (days after ischemia), the brain-blood barrier(BBB) disruption, as well as the accumulation of neutrophils and macrophage/ microglia in the brain, are the determinants in pathogenesis [31, 32] . The present study indicates that minocycline inhibits endogenous IgG exudation, an indicator of BBB disruption, as previously reported [30] . This effect of minocycline might result from the inhibition of neutrophil accumulation because the disrupted BBB has been reported to promote blood leukocyte recruitment [33] . However, resident microglia and hematogenous macrophages play similar roles in the pathogenetic cascade after cerebral ischemia; both are CD11b-positive, but the distinction between these cells has not been possible due to a lack of discriminating cellular markers [34] . Since minocycline inhibits microglial activation [11, 12] and BBB disruption, it might directly inhibit resident microglia activation and/or indirectly result from the inhibition of BBB disruption.
The most important finding in the present study is that minocycline may inhibit postischemic inflammation by inhibiting 5-LOX expression and enzymatic activation. Similarly, we also found that minocycline inhibited 5-LOX activation and exerted a protective effect on in vitro ischemiclike and excitotoxic injury in PC12 cells [19, 20] . 5-LOX activation has been reported in transient global ischemia [5, 6] and focal cerebral ischemia [7, 9] , and in the human brain tissue from stroke patients [8] . Recently, we found that 5-LOX expression and enzymatic activity increased after focal cerebral ischemia in rats, and were spatio-temporally involved in neuron injury in the acute phase and astrocyte proliferation in the late phase in vivo [10] . These findings indicate that 5-LOX may be a target of minocycline neuroprotection. Minocycline inhibits the activation of p38 mitogen-activated protein kinase (MAPK) [35, 36] , which may explain its effect on 5-LOX translocation or activation. As shown in neutrophils, activated p38 MAPK phosphorylates MAPK-activated protein kinase 2 and 3, which then directly phosphorylates 5-LOX; the phosphorylated 5-LOX translocates to the nuclear membrane and is activated to produce leukotrienes [37] . Therefore, minocycline possibly inhibits 5-LOX activation by modulating p38 MAPK activity. However, we could not explain why minocycline reduces the expression of 5-LOX, which may result from secondary responses due to attenuation of inflammation or from a special ability of minocycline.
The inhibition of 5-LOX activation may explain the antiinflammatory effects of minocycline. As supporting evidence, microglia, neutrophils, and macrophages possess the leukotriene-producing capacity of 5-LOX [38] [39] [40] . The 5-LOX metabolites, leukotrienes (LTB 4 and CysLT), are potent inflammatory mediators that can induce a variety of responses, such as chemotaxis of leukocytes [41] and BBB disruption [25, 42] . Therefore, reduction of leukotriene production by minocycline might attenuate postischemic inflammatory reactions. Additionally, minocycline possesses many other abilities that also relate to its anti-inflammatory effects, such as the inhibition of cytokine production [43] , iNOS [43] , metalloprotease activity [13] , and antioxidant ability [14] . However, as discordant evidence, no difference in ischemic infarcts has been found between 5-LOX-deficient and wild-type mice with focal cerebral ischemia [44] . We explained the discrepancy by 2 possibilities: one possibility is that 5-LOX deficiency may cause compensations as reported otherwise [45, 46] , which should be considered as an explanation for the results from wild-type and 5-LOX-deficient animals. Another possibility is that 5-LOX may act only as one factor in a complex system on ischemic brain injury; even if in arachidonic acid-metabolizing pathway, 5-LOX deficiency may enhance cyclooxygenase activity [47] . Recently, 5-LOX was confirmed as a modulator in rat focal cerebral ischemia in another laboratory [48] . Therefore, 5-LOX activation may be reasonably considered as one of the targets of minocycline.
In conclusion, we found that minocycline inhibited postischemic inflammation, partly mediated by the inhibition of 5-LOX expression and enzymatic activation.
